Minimally Invasive Glaucoma Surgery Devices Market Size, Trends, Analysis, and Outlook By Product (Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Others), By Surgery Method (Trabecular Meshwork Bypass, Suprachoroidal Space Implants, Subc

Minimally Invasive Glaucoma Surgery Devices Market Size, Trends, Analysis, and Outlook By Product (Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Others), By Surgery Method (Trabecular Meshwork Bypass, Suprachoroidal Space Implants, Subconjunctival Space Implants, Schlemm’s Canal Implants, Gonioscopy-assisted Transluminal Trabeculectomy, Endocyclophotocoagulation), By End-user ( Hospitals, Ophthalmic Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030

The global Minimally Invasive Glaucoma Surgery Devices market size is poised to register 5.92% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Minimally Invasive Glaucoma Surgery Devices market across By Product (Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Others), By Surgery Method (Trabecular Meshwork Bypass, Suprachoroidal Space Implants, Subconjunctival Space Implants, Schlemm’s Canal Implants, Gonioscopy-assisted Transluminal Trabeculectomy, Endocyclophotocoagulation), By End-user ( Hospitals, Ophthalmic Clinics, Others).

The Minimally Invasive Glaucoma Surgery (MIGS) Devices market is experiencing significant growth due to the rising prevalence of glaucoma, increasing adoption of minimally invasive surgical techniques, and advancements in device technology. MIGS devices are designed to reduce intraocular pressure (IOP) and manage glaucoma through less invasive procedures that offer quicker recovery times and fewer complications compared to traditional glaucoma surgeries. Factors such as the growing aging population, the rising incidence of glaucoma-associated risk factors such as diabetes and hypertension, and the expanding demand for safer and more effective treatment options are driving market expansion. Additionally, advancements in MIGS device design, materials, and surgical techniques, along with the development of novel implantable devices and combination therapies, are fueling innovation in the market. Moreover, the increasing adoption of MIGS procedures as a first-line treatment option for glaucoma, the expanding reimbursement coverage for MIGS devices, and the growing acceptance of micro-invasive surgical techniques by ophthalmologists and patients are driving market growth. Furthermore, efforts to optimize surgical outcomes, streamline patient selection criteria, and expand the clinical evidence base for MIGS devices are expected to further accelerate market growth in the coming years.

Minimally Invasive Glaucoma Surgery Devices Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Minimally Invasive Glaucoma Surgery Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Minimally Invasive Glaucoma Surgery Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Minimally Invasive Glaucoma Surgery Devices industry.

Key market trends defining the global Minimally Invasive Glaucoma Surgery Devices demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Minimally Invasive Glaucoma Surgery Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Minimally Invasive Glaucoma Surgery Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Minimally Invasive Glaucoma Surgery Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Minimally Invasive Glaucoma Surgery Devices industry

Leading Minimally Invasive Glaucoma Surgery Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Minimally Invasive Glaucoma Surgery Devices companies.

Minimally Invasive Glaucoma Surgery Devices Market Study- Strategic Analysis Review

The Minimally Invasive Glaucoma Surgery Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Minimally Invasive Glaucoma Surgery Devices Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Minimally Invasive Glaucoma Surgery Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Minimally Invasive Glaucoma Surgery Devices Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Minimally Invasive Glaucoma Surgery Devices Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Minimally Invasive Glaucoma Surgery Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Minimally Invasive Glaucoma Surgery Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Minimally Invasive Glaucoma Surgery Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Minimally Invasive Glaucoma Surgery Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Minimally Invasive Glaucoma Surgery Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Minimally Invasive Glaucoma Surgery Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Minimally Invasive Glaucoma Surgery Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Minimally Invasive Glaucoma Surgery Devices in Asia Pacific. In particular, China, India, and South East Asian Minimally Invasive Glaucoma Surgery Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Minimally Invasive Glaucoma Surgery Devices Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Minimally Invasive Glaucoma Surgery Devices Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Minimally Invasive Glaucoma Surgery Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Minimally Invasive Glaucoma Surgery Devices.

Minimally Invasive Glaucoma Surgery Devices Market Company Profiles

The global Minimally Invasive Glaucoma Surgery Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AlconInc, Glaukos Corp, Johnson & Johnson Vision, AbbVie Inc (Allergan plc), Corza Ophthalmology, Carl Zeiss Meditec AG, Katalyst Surgical, Lumenis Ltd, Ziemer Ophthalmic Systems AG, Iridex Corp

Recent Minimally Invasive Glaucoma Surgery Devices Market Developments

The global Minimally Invasive Glaucoma Surgery Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Minimally Invasive Glaucoma Surgery Devices Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Product

Valves

Glaucoma Drainage Implant

Glaucoma Tube Shunts

Stents

Others

By Surgery Method

Trabecular Meshwork Bypass

Suprachoroidal Space Implants

Subconjunctival Space Implants

Schlemm’s Canal Implants

Gonioscopy-assisted Transluminal Trabeculectomy

Endocyclophotocoagulation

By End-user

Hospitals

Ophthalmic Clinics

Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

AlconInc

Glaukos Corp

Johnson & Johnson Vision

AbbVie Inc (Allergan plc)

Corza Ophthalmology

Carl Zeiss Meditec AG

Katalyst Surgical

Lumenis Ltd

Ziemer Ophthalmic Systems AG

Iridex Corp

Formats Available: Excel, PDF, and PPT